Literature DB >> 5137312

Cellular immunity to renal carcinomas in man.

J Bubeník, J Jakoubková, P Krákora, M Baresová, P Helbich, V Viklický, V Malasková.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5137312     DOI： 10.1002/ijc.2910080319

Source DB:  PubMed          Journal:  Int J Cancer        ISSN： 0020-7136            Impact factor:   7.396


× No keyword cloud information.
  6 in total

1.  Lymphocytotoxicity to tumor target cells and interference of serum factors or tumor antigen with lymphocytotoxicity in patients suffering from different stages of breast carcinoma.

Authors:  H Warnatz; D Lackner; E Eder; F Scheiffarth; M Gruhl; O Bischoff
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1976-02-25

Review 2.  Cell-mediated tumour immunity in patients with transitional cell carcinoma of the urinary bladder.

Authors:  J Bubeník
Journal:  Int Urol Nephrol       Date:  1975       Impact factor: 2.370

3.  Tumour markers in urology: aids in cancer diagnosis and management.

Authors:  B Wahren
Journal:  Urol Res       Date:  1979-06-22

4.  In vitro cultivation of human renal cell cancer. I. Establishment of cells in culture.

Authors:  R D Williams; A Y Elliott; N Stein; E E Fraley
Journal:  In Vitro       Date:  1976-09

Review 5.  T cell targeting in cancer therapy.

Authors:  R L Bolhuis; E Sturm; E Braakman
Journal:  Cancer Immunol Immunother       Date:  1991       Impact factor: 6.968

6.  Cell surface antigens of human malignant melanoma: mixed hemadsorption assays for humoral immunity to cultured autologous melanoma cells.

Authors:  T E Carey; T Takahashi; L A Resnick; H F Oettgen; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1976-09       Impact factor: 11.205
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.